Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002514124 | SCV003445856 | likely pathogenic | not provided | 2023-08-18 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Tyr349 amino acid residue in NSDHL. Other variant(s) that disrupt this residue have been observed in individuals with NSDHL-related conditions (PMID: 15689440), which suggests that this may be a clinically significant amino acid residue. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 21265). This missense change has been observed in individuals with clinical features of CHILD syndrome (PMID: 14527740, 15689440, 18825599; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 349 of the NSDHL protein (p.Tyr349Cys). |
Gene |
RCV000020427 | SCV000040831 | not provided | Child syndrome | no assertion provided | clinical testing |